FindTrial
Sign In

Heterogeneity of Cancer-Associated Fibroblasts in Bladder Cancer Tumor Microenvironment and Its Prognostic Correlation Mechanism

Heterogeneity of Cancer-Associated Fibroblasts in Bladder Cancer Tumor Microenvironment and Its Prognostic Correlation Mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122497
Enrollment
Unknown
Registered
2026-04-14
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

bladder cancer:None

Sponsors

The Fifth Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The histological diagnosis is clear, the preservation conditions meet the experimental requirements, and complete clinical follow-up information is available.

Exclusion criteria

Exclusion criteria: 1. Incomplete organizational sample information, missing follow-up data, or incomplete clinical information.

Design outcomes

Primary

MeasureTime frame
CAFs-related gene expression level;Tumor cell proliferation ability;—

Countries

China

Contacts

Public ContactKang zhengjun,Duan wanlong

The Fifth Affiliated Hospital of Zhengzhou University

kzj7153@sina.com+86 375 6691 6741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026